Plus Therapeutics Secures Humana Coverage for CNS Cancer Assay
The agreement extends CNSide cerebrospinal fluid test coverage to 16 million additional patients nationwide.
Latest Articles
Editor's Top Picks
FDA Clears Automated Platform for Multiple Myeloma Diagnosis
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Lunit, Labcorp Partner on AI-Powered Digital Pathology Research
The collaboration combines Labcorp's clinical expertise with Lunit's AI algorithms to analyze tumor microenvironments and enhance biomarker discovery.
Equipment & Supply Spotlight
Security Vulnerabilities Found in Portable DNA Sequencers
Researchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
News, Know-How & Standards
Disease Detection & Understanding
BD HPV Assay Receives WHO Prequalification for Global Cervical Cancer Screening
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
